Correlation Between Enliven Therapeutics and MediciNova
Can any of the company-specific risk be diversified away by investing in both Enliven Therapeutics and MediciNova at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Enliven Therapeutics and MediciNova into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Enliven Therapeutics and MediciNova, you can compare the effects of market volatilities on Enliven Therapeutics and MediciNova and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Enliven Therapeutics with a short position of MediciNova. Check out your portfolio center. Please also check ongoing floating volatility patterns of Enliven Therapeutics and MediciNova.
Diversification Opportunities for Enliven Therapeutics and MediciNova
-0.09 | Correlation Coefficient |
Good diversification
The 3 months correlation between Enliven and MediciNova is -0.09. Overlapping area represents the amount of risk that can be diversified away by holding Enliven Therapeutics and MediciNova in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on MediciNova and Enliven Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Enliven Therapeutics are associated (or correlated) with MediciNova. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of MediciNova has no effect on the direction of Enliven Therapeutics i.e., Enliven Therapeutics and MediciNova go up and down completely randomly.
Pair Corralation between Enliven Therapeutics and MediciNova
Given the investment horizon of 90 days Enliven Therapeutics is expected to under-perform the MediciNova. But the stock apears to be less risky and, when comparing its historical volatility, Enliven Therapeutics is 3.83 times less risky than MediciNova. The stock trades about -0.19 of its potential returns per unit of risk. The MediciNova is currently generating about 0.13 of returns per unit of risk over similar time horizon. If you would invest 168.00 in MediciNova on September 3, 2024 and sell it today you would earn a total of 39.00 from holding MediciNova or generate 23.21% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Enliven Therapeutics vs. MediciNova
Performance |
| Timeline |
| Enliven Therapeutics |
| MediciNova |
Enliven Therapeutics and MediciNova Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Enliven Therapeutics and MediciNova
The main advantage of trading using opposite Enliven Therapeutics and MediciNova positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Enliven Therapeutics position performs unexpectedly, MediciNova can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in MediciNova will offset losses from the drop in MediciNova's long position.| Enliven Therapeutics vs. DiaMedica Therapeutics | Enliven Therapeutics vs. Lyra Therapeutics | Enliven Therapeutics vs. Centessa Pharmaceuticals PLC |
| MediciNova vs. DiaMedica Therapeutics | MediciNova vs. Lyra Therapeutics | MediciNova vs. Centessa Pharmaceuticals PLC |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.
Other Complementary Tools
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas |